NarcX offering is now closed and is no longer accepting investments.

Drug disposal eco-friendly solution

INVEST IN NARCX TODAY!

NarcX® provides a practical, effective and affordable solution to address the problem of drug disposal in the fight against the opioid crisis. We created an environmentally safe liquid solution that renders controlled substances such as pills, tablets, or liquids immediately non-divertible and ultimately non-retrievable.
... Show more
This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
NarcX

REASONS TO INVEST

Reasons Icon

The drug disposal industry is set to reach a value of $2 billion by 2025, and the push for onsite disposal solutions is growing.

Reasons Icon

Our proprietary, patent-pending solution renders prescription drugs, illicit drugs, and addictive substances non-retrievable for eco-friendly disposal.

Reasons Icon

Our team is composed of experienced professionals and passionate supporters committed to ending the opioid crisis.

OVERVIEW


Solving the Opioid Crisis Through Drug Disposal

According to independent validations from third-party laboratories, NarcX is the first and only independently validated method of on-site drug destruction that is in accordance with Drug Enforcement Administration’s (DEA) strict definition of non-retrievable as well as DEA's rules and regulations. 

We are disrupting the existing drug stockpiling, diversion, incineration and contamination process and replacing it with a simple solution. 



The NarcX liquid solution renders controlled substances immediately non-divertible and ultimately non-retrievable. This means that you can safely dispose of drugs  by pouring pills, tablets or liquids into NarcX containers.


*Images are computer-generated demo versions.

As the opioid crisis continues to claim the lives of people around all of us. It’s time to become part of the solution. 

It’s time for NarcX. 



THE PROBLEM


Addictions Often Stem from Unused Prescription Drugs

According to the Center for Disease Control and Prevention, the number of people dying from drug overdose has risen by 27% this year to over 240 a day.



Unused household prescription drugs are often not properly disposed of, which can lead to addiction. Approximately 80 percent of addicts admit they began their addiction with unused prescriptions in their house, a friends’ house, or neighbor's house. 



Source | Source | Source | Source


Medical centers, pharmacies, hospices, recovery clinics, and law enforcement agencies face similar challenges disposing of drugs, which may lead to cases of abuse, addiction and death. Incinerators are being closed every year, in the U.S., due to not complying with Environmental Protection Agency (EPA) rules and regulations. While these controlled substances are being stockpiled they are highly susceptible to diversion. These tragedies may have been avoided if the unused medication had been properly disposed of in the first place. 




THE SOLUTION


Safe, Eco-Friendly Disposal of Dangerous Drugs

We designed NarcX as a simple-to-use solution for controlled substance destruction. Pour in pills, capsules, tablets and liquids into the NarcX solution, close the bottle, and they are safely disposed of. 



NarcX breaks down all types of narcotics and addictive substances, including amphetamines and opiates, into an eco-friendly sludge that can be safely thrown away in the garbage. 

The bottle is only filled about ⅔ full to allow for the addition of medication waste. Once the bottle is full (liquid level reaches an inch below the cap), it is safe to be discarded in the normal household waste. Ensure that the cap is placed back onto the bottle and tightened down. 

 


Due to the high cost of incumbent drug disposal solutions, like incinerator solutions, NarcX is able to offer a substantially simpler and more affordable solution while maintaining a strong margin.


NarcX sells its liquid solution and implementation accessories to individuals and organizations who currently have, or will have, a need to dispose of expired, returned, or leftover drugs. 


*The above graphic contains images of our beta app which is currently not available for general use.







THE MARKET


Filling a Huge Need in a Growing Market

The pharmaceutical drug disposal market is a multi-billion dollar industry growing each year, expected to reach almost $2 billion by 2025. 

The DEA and EPA hold commercial and government entities responsible for destroying excess opioids without contaminating water sources. 

Source | Source


Historically, the only way to make a drug 100% non-retrievable was by contracting a DEA reverse distributor to deliver them to an incendiary plant. However, DEA reverse distributors are expensive and slow, creating many opportunities for misuse at each step in the custody chain. 


While most drug disposal is still done through incineration, the industry is moving towards on-site destruction to address diversion through new legislation, environmental concerns and savings opportunities.

Currently, NarcX is the only method on the market fulfilling this need for on-site destruction method. 


*Images are computer-generated demo versions.

OUR TRACTION


A Tested Product Brought to Market with Strong Partnerships

We have a proprietary product with a pending patent application. NarcX has been independently tested and validated by independent third parties to confirm its effectiveness.

NarcX is currently used by various healthcare systems, private businesses, and government agencies in the US. Our established partnerships with national distribution networks have already earned us over $250,000 in annual sales, and we are continuing to gain market traction. 



NarcX+

NarcX+ is recommended for law enforcement officers or healthcare professionals who come in contact with illicit drugs, including meth, heroin and cocaine. NarcX+ is designed to make all types of narcotics immediately non-retrievable. 


The following organizations are currently using and regularly ordering NarcX:

  • National Healthcare providers like, U.S. Veterans Affairs
  • Police Departments Criminal Laboratories, and Sheriff Offices
  • Hospitals and Medical Clinics
  • Pharmacies and Pharmaceutical corporations
  • National retail chains like PETCO




WHY INVEST


Using Our Product to Battle the Opioid Epidemic

NarcX is committed to the improvement of life, health and the environment. Our vision is for drugs to be disposed of in a safe and environmentally friendly manner; and to ultimately save lives that would otherwise be impacted by the opioid epidemic. 

We are meeting the needs of the multi-billion drug disposal market as the push for onsite disposal grows. Our proprietary solution for drug disposal is simple-to-use, effective, and eco-friendly. 



Our team is composed of experienced professionals and passionate supporters committed to ending the opioid crisis. 

Join us as we save lives and 
provide a solution to the opioid crisis.

Key Players 


  • Jim (James) Carroll serves as NarcX Advisory Board Member
  • Director of the White House Office of National Drug Control Policy (ONDCP) from Feb 2019 to Jan 2021
  • Acting Director and Deputy Director of ONDCP from Feb 2018 to Jan 2019
  • Under the leadership of Director Carroll, the United States saw its first annual decrease in overdose deaths for the first time in 30 years
  • Serves public, private, and non-profits in the area of healthcare, pharmaceuticals, drug policy, drug use prevention, and law enforcement
  • Former assistant to the U.S. President and Deputy Chief of Staff at the White House, General Counsel of the Office of Management and Budget, and as Deputy Assistant and Senior Counsel to the President.

  • David A. Schiller serves as NarcX Chief Compliance Officer & Co-Founder
  • Over 30 years of service with the Drug Enforcement Administration (DEA)
  • Overseeing DEA’s Diversion Control Program
  • Assistant Special Agent in Charge, DEA
  • Co-founded NarcX, the first and only “independently-validated” method of ”On-Site” disposal/destruction of controlled and non-controlled substances in the world.
  • Focused on solving the biggest problem in the United States over the last 20 years—the Opioid Epidemic.




ABOUT

HEADQUARTERS
523 E 1750 N, Suite 500
Vineyard, UT 84059
VALUATION
$35M

NarcX® provides a practical, effective and affordable solution to address the problem of drug disposal in the fight against the opioid crisis. We created an environmentally safe liquid solution that renders controlled substances such as pills, tablets, or liquids immediately non-divertible and ultimately non-retrievable.

TEAM

Jordan Erskine
Jordan Erskine
Chief Executive Officer

Jordan Erskine is a highly motivated entrepreneurial individual who has co-founded many successful businesses. Jordan has almost 20 years in the OTC/personal care/skincare industry. Jordan is currently a Co-Founder & Principal for the award-winning contract manufacturer Dynamic Blending.

Jordan has spent his entire career in the manufacturing and R&D world. Jordan started his career at a large contract manufacturing facility, Wasatch Product Development, in Draper Utah. At Wasatch Product Development he wore many hats in R&D, manufacturing, formulations, etc. He spent many years in R&D developing new and innovative personal care/skincare products. Jordan then moved on to a large dental manufacturing firm named Ultradent Products, Inc. Here, Jordan formulated and provided technical formulations assistance for two large Fortune 500 company accounts, Glaxo Smith-Kline and Colgate-Palmolive.

Jordan is passionate about helping to solve or mitigate the opioid epidemic. Jordan, and the rest of the dedicated NarcX® team, is excited to bring the only on-site medication disposal method to the market.

Jordan holds an MBA in International Business from Northeastern University.

David Schiller
David Schiller
Chief Compliance Officer

David Schiller is a former DEA Assistant Special Agent in Charge with over 30 years of experience with the United States Drug Enforcement Administration (DEA). Beginning with his hiring as a Special Agent in 1987, he was involved in investigating some of the largest criminal drug trafficking organizations throughout the world. After serving as the Executive Assistant to the Assistant Administrator in Arlington, Virginia, Schiller was reassigned in 2009 as the Assistant Special Agent in Charge (ASAC) for the Denver Field Division. He was subsequently assigned complete supervisory oversight for the DEA’s Diversion Program. This included supervisory oversight of all of the Tactical Diversion Squads and Diversion Groups in Colorado, Utah, Montana, and Wyoming. In this capacity, Schiller led the investigation of all criminal, administrative, and civil cases affecting every one of DEA’s Registrants, including manufacturers, distributors, pharmacies, hospitals, narcotic treatment providers, and doctors.

In 2015, Schiller was selected to be the Vice-Chair of DEA’s Diversion Field Advisory Committee (DFAC), with ultimate responsibility for coordinating all diversion-related matters for every one of DEA’s 21 Field Divisions in the United States. He ended his distinguished career by finalizing the largest administrative and civil settlement against a DEA Registrant in history—the McKesson Corporation. He retired from DEA in August 2017. Schiller’s vast experience and background were invaluable in co-founding NarcX® and contributing to the development of its game-changing products.

Christian Kasteler
Christian Kasteler
Director of Research & Development

Christian Kasteler is a Chemical Engineer with an emphasis in Bio-Chemical Engineering, working for over 15 years in the pharmaceutical industry. Christian believes that science and engineering can directly improve lives and enjoys taking an idea from concept to production. When tasked with developing a new product, he takes pride in delivering tangible, effective results that exceed expectations.

Christian has spent his career developing and producing pharmaceuticals, cosmetics, and medical devices. Christian is naturally curious and thrives on focusing his sharp, scientific mind on solving problems and creating effective solutions. Throughout his career, he has refined the processing of biodegradable polymers for esophageal chemotherapy treatment; developed innovative oral care products presently used within the dental industry; and worked as the Director of R&D for a compounding pharmacy. Christian currently serves as the Director of Research and Development at Dynamic Blending where he continues to generate positive results by developing a variety of drug, device, and cosmetic products. Christian’s experience was invaluable in the development of the NarcX® solution. When approached with the idea of creating a drug disposal product, he relied on his scientific expertise to develop the only DEA-compliant medication destruction method available today. Christian is proud to be a part of the NarcX® team. Christian holds a B.S. degree in Chemical Engineering from the University of Utah.

Gavin Collier
Gavin Collier
Chairman of the Board

Gavin began his education at Brigham Young University where he earned his Bachelor of Science in Biology. His major included emphasis in chemistry as well as Molecular, Micro, and Evolutionary Biology. With his scientific knowledge, Gavin worked in chemical formulations Research and Development for several years. Thereafter, Gavin continued his education and attended Law School where he earned his Doctor of Jurisprudence.

Gavin is a licensed attorney in the State of Utah and practiced in Federal and State Court. Gavin has demonstrated again and again his skill as a trial attorney and skilled negotiator. Gavin is aggressive, highly organized, and extremely detailed in all that he does. Gavin is also an entrepreneur and has co-founded Dynamic Blending Specialists, NarcX® as well as many other successful businesses.

Languages: English & Spanish

Jim Carroll

Jim Carroll

Board of Advisors

Jim (James) Carroll, principal and co-founder of DC Consulting LLC, a strategy and management consulting firm serving public, private, and non-profit clients offering services in the area of healthcare, pharmaceuticals, drug policy, drug use prevention, law enforcement, and communities.

Carroll previously served as the Director of the White House Office of National Drug Control Policy (ONDCP) from Feb 2019 to Jan 2021. Acting Director and Deputy Director of ONDCP from Feb 2018 to Jan 2019. Under the leadership of Director Carroll, the United States saw its first annual decrease in overdose deaths for the first time in 30 years; the number of drugs seized by law enforcement at our Nation’s borders stood at all-time highs; and record Federal grants were awarded in support of drug interdiction and public health programs.

In his role as “Drug Czar,” Carroll served as the principal advisor to the Administration on drug policy and managed a passionate staff of approximately 100 professionals. He oversaw a budget of more than $35 billion and successfully coordinated the activities and related funding of sixteen Federal government agencies and departments to reduce the supply of and demand for illicit substances.

Under the Trump Administration, Carroll also served as Assistant to the President and Deputy Chief of Staff at the White House, General Counsel of the Office of Management and Budget, and as Deputy Assistant and Senior Counsel to the President.

Under the George W. Bush Administration, served as Special Assistant and Associate Counsel to the President at the White House, Deputy General Counsel and Acting General Counsel at the U.S. Department of the Treasury, and as an attorney at the U.S. Department of Justice. 

Carroll also served as a state prosecutor in Virginia after earning his bachelor’s degree from the University of Virginia and his J.D. from the George Mason University School of Law.

Juan Riboldi

Juan Riboldi

Strategic Advisor

Juan serves as NarcX Strategic Advisor assisting the executive team on strategic decisions to deliver critical results, including capital strategies, capitalization initiatives, and investor relations.

Juan brings extensive experience working across the US and internationally with well-known Fortune 50 corporations and fast-growing private enterprises.

With a strong entrepreneurial background, Juan assists NarcX executives to identify, qualify, launch, and onboard strategic partnerships.

Juan has a Master's Degree in Business Management with an emphasis in Strategy, Organization, Leadership, and Mergers & Acquisitions from BYU, Harvard School of Business, and Wharton Business School.

TERMS

NarcX
Overview
PRICE PER SHARE
$1
DEADLINE
May 1, 2022
VALUATION
$35M
AMOUNT RAISED
$98,361.27
Breakdown
MIN INVESTMENT
$250.00
MAX INVESTMENT
$107,000.00
MIN NUMBER OF SHARES OFFERED
10,000
OFFERING TYPE
Equity
ASSET TYPE
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
1,070,000

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

NarcX Solutions Inc.

Corporate Address

:

523 E 1750 N, Suite 500, Vineyard, UT 84059

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,070,000.00

Minimum Investment Amount

(per investor)

:

$250.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

10,000

Maximum Number of Shares Offered

:

1,070,000

Price per Share

:

$1.00

Pre-Money Valuation

:

$35,000,000.00











*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Company Perks*

Time-Based:

Friends and Family Early Birds

Invest within the first 48 hours and receive an additional 20% bonus shares.

Super Early Bird Bonus

Invest within the first week and receive an additional 15% bonus shares.

Early Bird Bonus

Invest within the first two weeks and receive an additional 10% bonus shares. 

Amount-Based:

$500+ | Tier 1

NarcX Sample + Receive a personalized “Thank You” note from the NarcX team.

$1,000+ | Tier 2

FREE NarcX Product Sample + Receive a complimentary NarcX 6oz. bottle with a personalized “Thank You” note from the NarcX team.

$2,500+ | Tier 3

FREE NarcX Product Set + Receive a complimentary set of six NarcX 6oz. bottles with a personalized “Thank You” note from the NarcX team.

$5,000+ | Tier 4

Donate NarcX to a Drug Disposal Community Location + Donate a complementary set of six NarcX 6oz. Bottles to a drug disposal community location and receive a personalized “Thank You” note from the NarcX team.

$10,000+ | Tier 5

Donate NarcX to a Drug Disposal Community Location + Donate a complementary set of four NarcX 1 gallon bottles to a drug disposal community location and receive a personalized “Thank You” note from the NarcX team.

 

*All perks occur when the offering is completed.

The 10% StartEngine Owners’ Bonus

NarcX Solutions will offer 10% additional bonus shares of Common Stock for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer’s bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares of Common Stock which they purchase in this offering. For example, if you buy 100 shares of common shares at $1.00 / share, you will receive and own 110 shares of Common Stock for $100. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

PRESS

Article Image
KUTV

New initiative aims to end opioid crisis in Utah

Article Image
Fox13

Drug disposal bins in Riverton will dissolve pills on-site

Article Image
KSL TV

Riverton Introduces ‘Solution’ To Pill Disposal: NarcX

Article Image
Univision

Nuevo Plan Para Combatir Opioides

Article Image
Daily Herald

Vineyard partners with NarcX to help residents discard old prescriptions and pills










ALL UPDATES

03.17.22

NarcX signed a distribution agreement with SHS to provide NarcX for senior home care services

NarcX has entered into a distribution agreement with Seniors Home Services to provide a safe medication disposal solution to all of SHS clients. Senior Home Services is a one-stop solution for seniors and their families, enabling them to obtain the guidance, and the products and services, that make it possible for seniors to remain safely and comfortably in their homes for as long as possible. NarcX is enhancing SHS’s services by providing a safe way to dispose of unused or expired medication.

SHS goal is to be a comprehensive solution for seniors, allowing family members the peace of mind knowing their loved ones are safe, secure, and comfortable. NarcX is advancing SHS’s goal by providing a user-friendly and environmentally safe solution to medication disposal. NarcX is ramping up production capacity to meet the demand expected from SHS services.

03.09.22

NarcX being used by a growing number of healthcare services

There are multiple channels benefiting from NarcX. Just to name a few, hospital pharmacies, healthcare clinics, home care services, home medicine cabinets, recovery centers, law enforcement stations, pharmaceutical companies and medication manufacturers.

With such a wide-open market experiencing the pressing need for safe drug disposal, it is a challenge to know where to start and which distribution channels to prioritize. As we talk with end users looking for a solution to this problem, they often reveal that they had been looking for a product like NarcX and were not aware that NarcX existed.

Your investment in NarcX is opening up these large distribution channels and putting NarcX in the hands of the people who are looking for it. NarcX is now being used by a growing number of healthcare services. 

As these individual customers, healthcare venues and national distribution channels discover the value of NarcX, we expect demand to rapidly grow to fill a huge need in the market. Your investment is making this possible. The market response is clearly pointing to a fast-growing business opportunity. Thank you for being part of the solution to ending the opioid crisis. Thank you for investing in NarcX!

03.02.22

Over 40 Veteran Affairs Medical Centers are using NarcX

The largest healthcare provider network in the United States, the U.S. Veterans Affairs, has been a regular customer of NarcX. Since 2019, NarcX has been used by VA medical centers, outpatient clinics and pharmacies to facilitate proper drug disposal. Now, counting over 40 VA medical centers using NarcX as the preferred method for safely disposing of unused or expired medications, the VA is setting a standard for private healthcare systems across the nation and worldwide to adopt NarcX.

 


David Schiller, Co-Founder of NarcX, has been personally involved in many of the take-back programs being used at the various VAs. After more than 30 years of service overseeing DEA’s Diversion Control Program and as an Assistant Special Agent in Charge with the U.S. Drug Enforcement Administration (DEA), David brings a wealth of knowledge and practical experience to addressing the drug disposal issues fueling the opioid crisis. 

According to the National Institute of Health (NIH), nearly 50,000 people in the United States died from opioid-involved overdoses. Roughly 21 to 29 percent of patients prescribed opioids for chronic pain misuse them. Between 8 and 12 percent of people using an opioid for chronic pain develop an opioid use disorder. These casualties and derailed lives could be saved by using NarcX to immediately make the drugs unusable.

We celebrate the commitment of over 40 VA medical centers as well as many other hospitals, clinics and healthcare systems to supporting NarcX. We join with them in being part of the solution to end the opioid crisis. 

02.09.22

VA Medical Center Unveils New, Safe Drug Disposal System

Altoona, Pennsylvania area residents now have 24/7 access to dispose of unused or unwanted medications.

The Van Zandt VA Medical Center unveiled the NarcX Biodegradable Medication Disposal site on January 27, 2022. This allows anyone to safely dispose of pills and medications at the center.

“This is a shining example of going in and addressing issues in our community,” said Congressman John Joyce, who spoke at the event unveiling the NarcX disposal unit. “Having the NarcX as another tool is going to be very important toward battling this unfortunate epidemic.”

The NarcX unit became available for the public to use after the DUMP Opioids Act was put into effect this month. Congressman Joyce was one of the lead supporters of the act, which was approved unanimously by the Senate and House in July.

“This is a big part of the solution,” said Jim Carroll, the former Director of the Office of National Drug Control Policy. “This is another thing that we can use to combat this epidemic. The VA is still going to work in conjunction with law enforcement, local municipalities and other organizations, but this adds just another tool in our toolbox.”



“This addiction epidemic spares no one,” Joyce said. “Addiction is not specific to one socioeconomic group — it crosses all boundaries. … Each and every one of these individuals with addiction are suffering, and we have to take an all-hands-on-deck approach.”

Joyce encourages anyone with unused medications, both prescription or over the counter, to utilize the NarcX unit and “better protect their community.”

02.03.22

PETCO is using NarcX at Pet Care Locations

Pets, just like humans, use narcotics when going through surgery or other medical procedures. This means that veterinarians, just like pharmacists, deal with drug disposal issues. 



As a leader in pet health and wellness, Petco is constantly looking for innovative solutions. Since its founding in 1965, Petco has been trailblazing new standards in pet care. True to their mission to improve the lives of pets and deepen the bonds between pets and their pet parents, Petco needed a safe and effective method for disposing of unused or expired controlled drug wastage.

This is what led Amy Ebersole-Martinez, Petco Safety and Environmental Manager to explore options and consider NarcX. Soon, Amy and Petco’s veterinarians found that NarcX provides a safer and more effective approach to drug disposal. 

Now, over 45 Vetco Total Care locations are using NarcX. Comments from these locations indicate that NarcX is safer for staff, better for the environment, and good for the business. We also heard that NarcX is simple to use and order.

We look forward to building a successful partnership with Petco and help advance their mission. Thank you, Petco, for being part of the solution. Thank you for using NarcX.

01.04.22

NarcX starts 2022 with $100k+ in committed investments

Happy New Year! And big thanks as we start 2022 on a strong note.

NarcX investors continue to show their commitment to ending the opioid crisis as NarcX just reached the first $100k+ milestone in just a couple of weeks since we launched the crowdfunding campaign during the holidays.

Your investment is putting NarcX in the hands of more people. Moreover, your investment is making it possible for NarcX to provide a practical and effective method of onsite drug disposal that is eco-friendly, makes business sense and saves lives.

Thanks to each of you for supporting the mission of NarcX. We are committed to working with people like you, who share the NarcX vision.

Let’s make 2022 the year NarcX goes big! 

12.30.21

This Could Be You or Someone You Know.

Most of us are aware of the opioid epidemic. What most of us may not know is how drug addiction from unused medication left in our home medicine cabinets or confiscated narcotics stockpiled in clinics and police departments are affecting the lives of people we know, even our closest family and friends, and loved ones.

When we hired Chad to produce a NarcX documentary video, we knew he was an expert in getting the story right, blending facts and figures with real people’s experiences and powerful testimonials. Chad, a successful business owner and family man from California was touched, even disturbed, by what he was hearing about victims of drug addiction from improper disposal.

One day, while bringing NarcX sample bottles home from his video shoot, Chad remembered that his own medicine cabinet should still have a few leftover prescription medications. He knew that these medications had not been fully used.

Intent on making use of NarcX, he went directly to the kitchen medicine cabinet and searched for the bottles. He wanted to remove the possibility of these medications ending up in the wrong hands. He found the bottles empty. The leftover pills were gone!

“Who took them?” Chad wondered. From his own kitchen medicine cabinet, the pills were gone. And no one knew where. Had NarcX been used sooner, the leftover pills would have been promptly destroyed . . . and more drug addiction could have been averted.



According to the U.S. Drug Enforcement Administration, approximately 80 percent of addicts admit they began their addiction with a prescription drug not prescribed for them by a doctor, but from unused prescriptions in their house, a friend’s house, or neighbor’s house.

Most of us know someone that has become addicted or has died due to drug overdose. These tragedies could have been avoided if the unused medication would have been properly disposed of in the first place.

Make a difference to end the opioid crisis. Invest in NarcX.

12.29.21

Meet the Team. Driven to Make a Difference!

When David Schiller retired from the U.S. Drug Enforcement Administration (DEA) after over 30 years of service overseeing DEA’s Diversion Control Program, and as an Assistant Special Agent in Charge, he was contemplating retirement. David still felt a drive to do more to put an end to the opioid crisis, a subject he knows well.

It was at that point that he was approached with a group of successful personal care entrepreneurs and chemist scientists with NarcX. David quickly dismissed them knowing that no product in the market at that time met the strict criteria for drug disposal set by the DEA.

The NarcX team became even more interested in David’s definitive and authoritative industry standards and of his knowledge and contacts in the industry. David gave them a list of near impossible requirements that a product like NarcX would have to meet to be effective. List on hand, the NarcX team went to work.

Months later, they demonstrated to David and others that NarcX was now formulated to meet all the items on the checklist. David was intrigued but unconvinced. He asked for third party validation. Months later three independent labs came back with favorable results proving that NarcX worked as intended.

Since then, David joined the NarcX team and brought along key players, including Jim (James) Carroll who now serves as NarcX Advisory Board Member. Jim has served as Director of the White House Office of National Drug Control Policy (ONDCP) from Feb 2019 to Jan 2021. Under the leadership of Director Carroll, the United States saw its first annual decrease in overdose deaths for the first time in 30 years.

Other notable founders include Jordan Erskine, CEO, Gavin Collier, Chairman, and Christian Kasteler, Director of R&D, all three successful entrepreneurs and personal care industry experts. The founders as well as many others continue to be driven to making a difference through NarcX to be part of the solution to end the opioid crisis.

Now, you too can be part of this story of success through your investment in NarcX.


12.27.21

How NarcX is Disrupting Drug Disposal

What happens to most unused medication, expired drugs, or confiscated narcotics?

Much of it ends up in the wrong hands, creating addiction or contaminating the environment.

The current methods for disposing of prescription medication and illegal drugs require long periods of stockpiling, lead to contamination of water systems, and are highly susceptible to diversion (misuse).  NarcX is a simple solution to a huge and complex problem. Moreover, NarcX is the first and only independently validated method of on-site drug destruction.

NarcX is incredibly simple, effective and economic way for disposing leftover medication and confiscated narcotics.

Step 1: Pour in the pills, capsules, tablets and liquids into the NarcX solution.

Step 2: Close the bottle.  NarcX immediately renders all types of addictive substances non-divertible and ultimately non-retrievable in an eco-friendly sludge.

Step 3: When the liquid level reaches an inch below the NarcX bottle cap, safely throw away in the garbage.

Your investment in NarcX is making it possible for us to be part of ending the opioid crisis. Your investment makes a difference!


12.22.21

$70K+ in committed investments

Wow! Your amazing interest in NarcX in just the first few days since we launched shows that you and many others are willing to invest in being part of the solution to end the opioid crisis. 

We launched NarcX on StartEngine last Friday, December 17, right before the holidays. We didn’t know what to expect, and we had an overwhelming response to the campaign. In only a few days, over the weekend, we reached over $70K by Monday morning.

Thanks to each of you for supporting the mission of NarcX. We are committed to providing a practical method for onsite drug disposal that is environmentally safe, makes business sense and saves lives.

People like you, who share the NarcX vision, inspire us to make it happen. 

We are interested to hearing your comments. Tell us what motivates you to invest in NarcX. Please drop us a comment so we can get to know you.

Thank you for being part of the solution!










REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into NarcX.

$250.00

StartEngine Owner’s Bonus

This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$500.00

Tier 1

NarcX Sample + Receive a personalized “Thank You” note from the NarcX team.

$1,000.00

Tier 2

FREE NarcX Product Sample + Receive a complimentary NarcX 6oz. bottle with a personalized “Thank You” note from the NarcX team.

$2,500.00

Tier 3

FREE NarcX Product Set + Receive a complimentary set of six NarcX 6oz. bottles with a personalized “Thank You” note from the NarcX team.

$5,000.00

Tier 4

Donate NarcX to a Drug Disposal Community Location + Donate a complementary set of six NarcX 6oz. Bottles to a drug disposal community location and receive a personalized “Thank You” note from the NarcX team.

$10,000.00

Tier 5

Donate NarcX to a Drug Disposal Community Location + Donate a complementary set of four NarcX 1 gallon bottles to a drug disposal community location and receive a personalized “Thank You” note from the NarcX team.

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.